What Is a Bicuspid Aortic Valve — and Why Does It Matter?
A normal aortic valve has three thin leaflets that open and close with each heartbeat, directing blood from the heart into the aorta and out to the rest of the body. A bicuspid aortic valve (BAV) has only two functional leaflets instead of three. It is the most common congenital heart defect, affecting roughly 1 to 2 percent of the general population — and it is significantly more prevalent in men than women.
Many people live for decades without knowing they have a bicuspid valve. It is often discovered incidentally during an echocardiogram or physical exam when a doctor hears a heart murmur. But a bicuspid aortic valve is not simply an anatomic curiosity. Over time, it can lead to serious complications that require intervention.
The two most important problems associated with BAV are:
- Aortic stenosis — progressive narrowing and calcification of the valve, which forces the heart to work harder to pump blood forward.
- Aortic regurgitation (insufficiency) — incomplete closure of the valve, allowing blood to leak backward into the heart with each beat.
In addition, roughly 40 to 50 percent of patients with a bicuspid aortic valve also develop enlargement (dilation) of the ascending aorta, a condition called aortopathy. This is not merely a consequence of abnormal flow through the valve — it reflects an intrinsic weakness in the aortic wall tissue itself. Left unmonitored, this can progress to aortic aneurysm or, in rare cases, aortic dissection.
Understanding that BAV is a disease of both the valve and the aorta is essential. It is one of the reasons I encourage patients diagnosed with a bicuspid valve to seek care from physicians experienced with this specific condition — and to get a thorough evaluation that looks beyond the valve alone.
BAV Treatment Options: From Surveillance to Surgery
Not every bicuspid aortic valve needs surgery. In fact, many patients with BAV require only regular monitoring for years or even decades. The key is knowing where you fall on the spectrum and having a clear, individualized plan.
Active Surveillance
If your bicuspid valve is functioning well — meaning it is not severely stenotic or significantly regurgitant — and your aorta is of normal or only mildly enlarged size, the appropriate strategy is surveillance. According to the 2020 ACC/AHA Guidelines for the Management of Valvular Heart Disease, patients with a well-functioning bicuspid valve should have echocardiographic imaging at regular intervals, typically every one to two years, depending on the degree of valve dysfunction and aortic size.
During surveillance, your physician will track several things:
- The degree of stenosis or regurgitation on echocardiogram
- Your aortic root and ascending aortic dimensions (often with CT or MRI in addition to echo)
- Your symptoms — or lack thereof
- Left ventricular size and function
Surveillance is not passive. It is an active, structured process that ensures we detect progression early enough to intervene at the optimal time — before irreversible damage to the heart occurs.
Medical Management
There is no medication that can stop a bicuspid valve from degenerating over time. However, medical therapy plays a supporting role. Blood pressure control is particularly important in patients with aortic dilation. Beta-blockers or angiotensin receptor blockers (ARBs) are sometimes used to reduce aortic wall stress, drawing on evidence extrapolated from the management of Marfan syndrome and other connective tissue disorders.
Patients with BAV should also receive endocarditis prophylaxis counseling. While routine antibiotic prophylaxis before dental procedures is no longer universally recommended for native valve disease, patients with a history of prior endocarditis or prosthetic valve replacement do require it. Your cardiologist should clarify your specific situation.
Surgical Intervention
When a bicuspid aortic valve develops severe stenosis, severe regurgitation, or when the aorta enlarges beyond safe thresholds, surgery becomes necessary. The specific type of surgery depends on several factors I will outline below.
Bicuspid Valve Surgery Timing: When Is the Right Moment?
This is the question I am asked most often by patients and families facing a BAV diagnosis: When do I actually need surgery? The answer depends on what the valve is doing, what the aorta is doing, and whether you have symptoms.
Surgery for Aortic Stenosis
Surgical aortic valve replacement is indicated when stenosis becomes severe (typically defined as a valve area less than 1.0 cm², a mean gradient above 40 mmHg, or a peak velocity above 4.0 m/s) and the patient has symptoms such as exertional shortness of breath, chest pain, or syncope. Surgery is also indicated in asymptomatic patients with severe stenosis if the left ventricle is starting to weaken (ejection fraction dropping below 50%) or if the patient is undergoing another cardiac surgery.
The critical point: do not wait until symptoms are debilitating. Studies consistently show that outcomes are significantly better when surgery is performed before the heart sustains irreversible damage. Delayed referral for valve replacement is one of the most common — and most preventable — mistakes I see.
Surgery for Aortic Regurgitation
Severe aortic regurgitation warrants surgery when symptoms develop, when the left ventricle begins to dilate or its function declines (ejection fraction below 55%, or left ventricular end-systolic dimension greater than 50 mm), or when another cardiac procedure is being performed. Again, the emphasis is on timely intervention. Chronic volume overload from severe regurgitation can lead to irreversible left ventricular dysfunction if surgery is delayed too long.
Surgery for Aortic Dilation (Aortopathy)
According to ACC/AHA guidelines, surgical replacement of the ascending aorta is recommended when the diameter reaches 5.5 cm in patients with a bicuspid aortic valve, or 5.0 cm if the patient has additional risk factors for dissection — including a family history of aortic dissection, rapid rate of aortic growth (more than 0.5 cm per year), or coarctation of the aorta. If a patient is already undergoing valve surgery, many surgeons will replace the ascending aorta at a lower threshold (typically 4.5 cm) to avoid the need for a second operation later.
This is an area where expert judgment matters enormously. The decision to include aortic replacement at the time of valve surgery requires a surgeon who understands the natural history of bicuspid aortopathy and who can weigh the incremental operative risk against the long-term benefit. If you have questions about whether aortic repair should be part of your surgical plan, a cardiac surgery second opinion can provide clarity.
Bicuspid Aortic Valve Surgery: Repair, Replacement, and Aortic Reconstruction
Once the decision for surgery is made, the next question is: what kind of operation?
Aortic Valve Repair
In selected patients — particularly younger patients with aortic regurgitation from a bicuspid valve — aortic valve repair is an attractive option. Repair preserves the native valve tissue, avoids the need for lifelong anticoagulation (blood thinners), and may offer better hemodynamic performance than a prosthetic valve. Techniques include leaflet repair, annuloplasty (reinforcing the valve ring), and raphe resection.
However, valve repair for bicuspid disease is technically demanding and its durability depends heavily on the surgeon's experience. Not every bicuspid valve is amenable to repair. Long-term data from experienced centers show that roughly 10 to 15 percent of repaired bicuspid valves will require reoperation within 10 to 15 years. If repair is being considered, I strongly encourage patients to confirm that their surgeon has a substantial track record with this specific procedure.
Aortic Valve Replacement
When repair is not feasible — which is the case for most patients with calcific bicuspid aortic stenosis — valve replacement is the standard approach. The two main options are:
- Mechanical valve: Extremely durable (can last a lifetime), but requires lifelong warfarin anticoagulation with regular blood monitoring (INR checks). Best suited for younger patients who can tolerate long-term blood thinner therapy.
- Bioprosthetic (tissue) valve: Does not require long-term anticoagulation in most cases, but has a limited lifespan. Modern tissue valves last approximately 15 to 20 years in older patients, but may degenerate faster in younger, more active individuals.
The choice between a mechanical and tissue valve is deeply personal and depends on your age, lifestyle, tolerance for blood thinners, and plans for the future. There is no universally right answer — but there is a right answer for you, and it deserves a thorough discussion.
The Ross Procedure
For younger patients, the Ross procedure is a specialized alternative. In this operation, the diseased aortic valve is replaced with the patient's own pulmonary valve (autograft), and the pulmonary valve is then replaced with a donor valve (homograft). The advantage is excellent hemodynamics and freedom from anticoagulation. The disadvantage is the complexity of the operation and the fact that it turns a single-valve disease into a two-valve issue over time. This procedure should only be performed at experienced centers.
TAVR for Bicuspid Valves
Transcatheter aortic valve replacement (TAVR) has transformed the treatment of aortic stenosis in older, higher-risk patients with three-leaflet (trileaflet) valves. Its role in bicuspid aortic valve disease is more limited and evolving. The asymmetric anatomy of a bicuspid valve increases the risk of paravalvular leak, uneven valve expansion, and other complications with TAVR. Current guidelines recommend surgical valve replacement as the standard of care for most patients with bicuspid aortic stenosis, though TAVR may be considered in carefully selected higher-risk patients. This is an area where individual assessment is critical.
Combined Valve and Aortic Surgery
Many patients with BAV need both valve surgery and ascending aortic replacement. This is a well-established combined operation — sometimes called a Bentall procedure when the aortic root is also involved, or a separate valve replacement with supracoronary aortic graft. Operative mortality for elective combined procedures at experienced centers is low, typically in the range of 1 to 3 percent. Understanding your individual risk is important, and our free cardiac surgery risk calculator can give you an initial estimate based on established scoring systems.
Practical Advice for Patients Living With a Bicuspid Aortic Valve
Whether you are in the surveillance phase or approaching a surgical decision, here are the things I tell my own patients:
- Do not skip your imaging follow-ups. BAV disease can progress silently. Regular echocardiograms and periodic CT or MRI of the aorta are your safety net.
- Ask about your aorta, not just your valve. Every time you have an echocardiogram, confirm that the ascending aortic dimensions were measured and reviewed. If your aorta is enlarged, insist on gated CT angiography or MRI for more precise measurement.
- Control your blood pressure. Hypertension accelerates aortic dilation. Aim for a systolic blood pressure below 130 mmHg in most cases.
- Understand the exercise conversation. Many patients with BAV can exercise safely, but certain activities — particularly heavy isometric weightlifting — may be restricted if the aorta is significantly enlarged. Have this conversation with your cardiologist.
- Inform your family. BAV has a heritable component. First-degree relatives of patients with a bicuspid valve should be screened with echocardiography. Studies suggest the prevalence of BAV in first-degree relatives is approximately 9 percent — far higher than the general population.
- If surgery is recommended, ask the right questions. How many bicuspid valve operations does the surgeon perform per year? Is valve repair an option? Will the aorta be addressed? What type of valve prosthesis is recommended and why? These are not impolite questions — they are essential.
When to Seek a Second Opinion on Your Bicuspid Valve Plan
I have reviewed cases where patients were told to wait when they should have been referred for surgery, and cases where surgery was proposed prematurely. Both scenarios carry real consequences. A second opinion is particularly valuable when:
- You have been told you need surgery but want to confirm the timing is right
- You have been told to "just watch" a valve or aorta that seems to be progressing
- You have been offered TAVR for a bicuspid valve and want to understand whether surgical replacement may be more appropriate
- You are a younger patient weighing mechanical vs. tissue valve vs. the Ross procedure
- Aortic dilation is present and you want to know whether combined surgery is indicated
A second set of expert eyes can either confirm your current plan — giving you confidence to move forward — or identify an alternative strategy that may lead to a better long-term outcome. You can learn more about how our review process works.
If you are facing a decision about your bicuspid aortic valve — whether it involves the timing of surgery, the type of valve, or whether your aorta needs attention — a WhiteGloveMD second opinion can help. Our team, led by a board-certified cardiovascular surgeon, will review your imaging, your records, and your specific clinical situation, then provide a clear, actionable recommendation. Start your review today and make your next decision with confidence.